The MIND Diet May Help Prevent Alzheimer’s By Camille Noe PagánWebMD Feature Reviewed by Neil Lava, MD Want another great reason to eat healthy? Researchers have found that people who stuck to a diet that included foods like berries, leafy greens, and fish had a major drop in their risk for the memory-sapping disorder, which affects more than 5 million Americans over age 65. The eating plan is called the MIND diet. Brain-Friendly Foods MIND stands for Mediterranean-DASH Intervention for Neurodegenerative Delay. But the MIND approach “specifically includes foods and nutrients that medical literature and data show to be good for the brain, such as berries,” says Martha Clare Morris, ScD, director of nutrition and nutritional epidemiology at Rush University Medical Center. You eat things from these 10 food groups: You avoid: The Benefits One study showed that people who stuck to the MIND diet lowered their risk of Alzheimer’s disease by 54%. Scientists need to do more research on the MIND approach, “but it’s a very promising start.
About / Julie's Bicycle Julie’s Bicycle is a leading global charity bridging the gap between environmental sustainability and the creative industries. Our vision is a creative community with sustainability at its heart and our mission is to provide the inspiration, expertise and resources to make that happen. We work with over 1,000 arts organisations across the UK and internationally, large and small to help them measure, manage and reduce their environmental impacts. Julie's Bicycle does three things: Expertise Rooted in our ongoing research progamme delivered in partnership with Oxford University, we gather the environmental data of almost 2,000 creative organisations via our Creative Industry Green Tools (now a funding requirement for Arts Council England and shortly Creative Scotland). We are consulting and certifying over 70 creative organisations, working across the European Union and advising on international cultural policy. Capacity Building Thought Leadership
home PSA Levels: PSA Blood Tests and Prostate Cancer Screening Prostate-Specific Antigen (PSA) Blood Test Prostate-specific antigen (PSA) is a substance produced by the prostate gland. Elevated PSA levels may indicate prostate cancer, a noncancerous condition such as prostatitis, or an enlarged prostate. Most men have PSA levels under four (ng/mL) and this has traditionally been used as the cutoff for concern about the risk of prostate cancer. In the past, most experts viewed PSA levels less than 4 ng/mL as normal. Just as important as the PSA number is the trend of that number (whether it is going up, how quickly, and over what period of time). slideshow Does This Cause Cancer? start How Is The PSA Screening Test Done? The test involves drawing blood, usually from the arm.
Eco Action Partnership - home Jobs at Nonprofits, Jobs at Foundations Juno Therapeutics and Kite Pharma: The Danger of Alarmingly Thin Data -- The Motley Fool Image source: Getty Images. As Juno Therapeutics (NASDAQ:JUNO) and Kite Pharma (NASDAQ:KITE) ramp up for a potential 2017 or early 2018 launch of their lead CAR-T therapies, investor caution is advised. Although the companies' cancer-killing immune cell therapies represent an exciting leap forward in cancer treatment, both companies are approaching pivotal FDA decisions, which could make or break these stocks. The pot of gold at the end of the rainbow is huge -- peak sales estimates of CAR-T therapies run up to $10 billion annually. But these therapies are highly unusual, they have a nasty track record for toxicity, and it's hard to know how regulators will view them. There's one more big gotcha looming. Here's a closer look at why investor skepticism (as well as some guarded optimism) could be in order. Juno is behind on its launch date, but it has strong data In early July, Juno's stock took a wild, 180-degree turn after a critical study for its lead CAR-T therapy was halted.
eco-controlling: ecocontrolling PublicHealthJobs.net -- ASPH's FREE Public Health Employment Resource -- public health jobs, careers, employment The Chocolate Revolution HERE ARE THREE DIFFERENT types of cocoa bean which are used in chocolate production today. They are the noble Criollo, the common Forastero and a hybrid between the two, the Trinitario. Criollo and Trinitario are often referred to as fine or flavour cocoa beans, while Forastero is considered the ordinary or bulk bean for mass production (although there are exceptions to this rule -- see below). Over 90% percent of the world's cocoa is bulk production, mostly from the Forastero bean. What the fine Arabica bean is to coffee, the even finer and rarer Criollo bean is to chocolate. This is the equivalent of the Robusta bean in coffee, namely the most widespread variety which has been cultivated for mass production. Trinitario is a hybrid between the Criollo and Forastero trees and originated in Trinidad.
Go Group | Green Operations Europe The Job Board for Media Professionals NASA „breytti“ ekki stjörnumerkjunum Skelfing greip um sig á meðal þeirra sem leggja trúnað í stjörnuspár þegar orðrómur fór á kreik um að NASA hefði „breytt“ stjörnumerkjunum með þeim afleiðingum að 86% fólks væri ekki lengur í því stjörnumerki sem það taldi. Greip NASA á það ráð að bera orðróminn til baka og útskýra að stjörnuspeki væri ekki vísindi. Þrátt fyrir að ekkert bendi til þess að staðsetning sólarinnar gagnvart stjörnuhimninum frá jörðinni séð hafi þýðingu fyrir skapgerð fólks eða spágildi um framtíðina eru enn til einstaklingar sem fylgjast grannt með stjörnuspám sem birtast meðal annars í dagblöðum og tímaritum. Þeim brá því nokkuð í brún þegar sögusagnir fóru á kreik í síðustu viku um að bandaríska geimvísindastofnunin hafi einhliða breytt stjörnumerkjunum. Cosmopolitan virðist hafa túlkað þá augljósu fullyrðingu sem svo að NASA hefði breytt dagsetningum stjörnumerkjanna. Stjörnuhimininn hefur „hliðrast“ á þúsundum ára